Clinical Trial Update: Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety, tolerability, and efficacy of AEB071 for uveitis shows completed study; regulatory implications pending.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panuveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• AEB071 (sotrastaurin)

Snippet

Sponsor: Novartis | Conditions: Uveitis, Posterior Uveitis | Phase 2 | Status: COMPLETED